Effects of Aripiprazole on Olanzapine Population Pharmacokinetics and Initial Dosage Optimization in Schizophrenia Patients.

Authors:
Zhang C; Jiang L; Hu K; Chen L; Zhang YJ and 4 more

Journal:
Neuropsychiatr Dis Treat

Publication Year: 2024

DOI:
10.2147/NDT.S455183

PMCID:
PMC10925492

PMID:
38469209

Journal Information

Journal Title: Neuropsychiatr Dis Treat

Detailed journal information not available.

Publication Details

Subject Category: Psychiatry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure Cun Zhang, Lei Jiang, and Ke Hu are co-first authors for this study. The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties."

Evidence found in paper:

"This work was supported by National Natural Science Foundation of China (No. 82104296), The Xuzhou Special Fund for Promoting Scientific and Technological Innovation (No. KC23217, No. KC23254), The Medical Research Project of Jiangsu Provincial Health Commission (No. Z2023010), The Initializing Fund of Xuzhou Medical University (No. RC20552111, No. RC20552222), The Fusion Innovation Project of Xuzhou Medical University (No. XYRHCX2021011, No. XYRHCX2022005), Jiangsu Province Education Science Planning Project (No. C/2022/01/36), Xuzhou Medical University Labor Education Special Project (No. X1d202209), Jiangsu Province Higher Education Informatization Research Topic (No. 2023JSETKT136), Xuzhou Medical University Research Topic of Higher Education Teaching Reform (No. Xjyzrd202304)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025